SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Wei Luo, Candace S. Johnson, Donald L. Trump, Vitamin D Hormone, 2016,

    CrossRef

  2. 2
    T B Dorff, S Groshen, D D Tsao-Wei, S Xiong, M E Gross, N Vogelzang, D I Quinn, J K Pinski, A Phase II trial of a combination herbal supplement for men with biochemically recurrent prostate cancer, Prostate Cancer and Prostatic Disease, 2014, 17, 4, 359

    CrossRef

  3. 3
    C. Leyssens, L. Verlinden, A. Verstuyf, Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancer, Endocrine Related Cancer, 2013, 20, 2, R31

    CrossRef

  4. 4
    Nicholas G. Zaorsky, Ganesh V. Raj, Edouard J. Trabulsi, Jianqing Lin, Robert B. Den, The Dilemma of a Rising Prostate-Specific Antigen Level After Local Therapy: What Are Our Options?, Seminars in Oncology, 2013, 40, 3, 322

    CrossRef

  5. 5
    Katherine D. Crew, Vitamin D: Are We Ready to Supplement for Breast Cancer Prevention and Treatment?, ISRN Oncology, 2013, 2013, 1

    CrossRef

  6. You have free access to this content6
    Cheryl L. Rock, Colleen Doyle, Wendy Demark-Wahnefried, Jeffrey Meyerhardt, Kerry S. Courneya, Anna L. Schwartz, Elisa V. Bandera, Kathryn K. Hamilton, Barbara Grant, Marji McCullough, Tim Byers, Ted Gansler, Nutrition and physical activity guidelines for cancer survivors, CA: A Cancer Journal for Clinicians, 2012, 62, 4
  7. 7
    Aruna V. Krishnan, David Feldman, Mechanisms of the Anti-Cancer and Anti-Inflammatory Actions of Vitamin D, Annual Review of Pharmacology and Toxicology, 2011, 51, 1, 311

    CrossRef

  8. 8
    Jong-Wei Hsu, Sayeda Yasmin-Karim, Michael R. King, Joel C. Wojciechowski, Deanne Mickelsen, Martha L. Blair, Huei-Ju Ting, Wen-Lung Ma, Yi-Fen Lee, Suppression of Prostate Cancer Cell Rolling and Adhesion to Endothelium by 1α,25-Dihydroxyvitamin D3, The American Journal of Pathology, 2011, 178, 2, 872

    CrossRef

  9. 9
    Hidekazu Koike, Yasuyuki Morikawa, Yoshitaka Sekine, Hiroshi Matsui, Yasuhiro Shibata, Kazuhiro Suzuki, Survivin Is Associated With Cell Proliferation and Has a Role in 1a,25-Dihydroxyvitamin D3 Induced Cell Growth Inhibition in Prostate Cancer, The Journal of Urology, 2011, 185, 4, 1497

    CrossRef

  10. 10
    Anna Woloszynska-Read, Candace S. Johnson, Donald L. Trump, Vitamin D and cancer: Clinical aspects, Best Practice & Research Clinical Endocrinology & Metabolism, 2011, 25, 4, 605

    CrossRef

  11. 11
    Srilatha Swami, Aruna V. Krishnan, David Feldman, Vitamin D metabolism and action in the prostate: Implications for health and disease, Molecular and Cellular Endocrinology, 2011, 347, 1-2, 61

    CrossRef

  12. 12
    Khanh vinh quoc Luong, Lan Thi Hoang Nguyen, The beneficial role of vitamin D and its analogs in cancer treatment and prevention, Critical Reviews in Oncology/Hematology, 2010, 73, 3, 192

    CrossRef

  13. 13
    Lori A. Plum, Hector F. DeLuca, Vitamin D, disease and therapeutic opportunities, Nature Reviews Drug Discovery, 2010, 9, 12, 941

    CrossRef

  14. 14
    Aruna V. Krishnan, Sandy Srinivas, David Feldman, Inhibition of prostaglandin synthesis and actions contributes to the beneficial effects of calcitriol in prostate cancer, Dermato-Endocrinology, 2009, 1, 1, 7

    CrossRef

  15. 15
    D. Robert Siemens, Jeremy P.W. Heaton, Michael A. Adams, Jun Kawakami, Charles H. Graham, Phase II Study of Nitric Oxide Donor for Men With Increasing Prostate-specific Antigen Level After Surgery or Radiotherapy for Prostate Cancer, Urology, 2009, 74, 4, 878

    CrossRef

  16. 16
    Thomas E. Newsom-Davis, Laura M. Kenny, Sarah Ngan, Judith King, Jonathan Waxman, The promiscuous receptor, BJU International, 2009, 104, 9
  17. 17
    John A Taylor III, Carol Pilbeam, Andrew Nisbet, Role of the prostaglandin pathway and the use of NSAIDs in genitourinary malignancies, Expert Review of Anticancer Therapy, 2008, 8, 7, 1125

    CrossRef

  18. 18
    Joanna Wietrzyk, Dmitry Nevozhay, Magdalena Milczarek, Beata Filip, Andrzej Kutner, Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model, Cancer Chemotherapy and Pharmacology, 2008, 62, 5, 787

    CrossRef

  19. 19
    DAVID FELDMAN, PETER J. MALLOY, ARUNA V. KRISHNAN, EVA BALINT, Osteoporosis, 2008,

    CrossRef

  20. 20
    Aruna V Krishnan, Jacqueline Moreno, Larisa Nonn, Srilatha Swami, Donna M Peehl, David Feldman, Calcitriol as a Chemopreventive and Therapeutic Agent in Prostate Cancer: Role of Anti-Inflammatory Activity, Journal of Bone and Mineral Research, 2007, 22, S2
  21. 21
    Aruna V. Krishnan, Jacqueline Moreno, Larisa Nonn, Peter Malloy, Srilatha Swami, Lihong Peng, Donna M. Peehl, David Feldman, Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer, The Journal of Steroid Biochemistry and Molecular Biology, 2007, 103, 3-5, 694

    CrossRef

  22. 22
    Tomasz M. Beer, Milind M. Javle, Christopher W. Ryan, Mark Garzotto, Gilbert N. Lam, Alvin Wong, W. David Henner, Candace S. Johnson, Donald L. Trump, Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer, Cancer Chemotherapy and Pharmacology, 2007, 59, 5, 581

    CrossRef

  23. You have free access to this content23
    Aruna V. Krishnan, Srilatha Swami, Jacqueline Moreno, Rumi B. Bhattacharyya, Donna M. Peehl, David Feldman, Potentiation of the Growth-Inhibitory Effects of Vitamin D in Prostate Cancer by Genistein, Nutrition Reviews, 2007, 65,
  24. 24
    Gilles Salama, Olivier Noirot, Vincent Bataille, Sandra Malavaud, Xavier Rebillard, Arnauld Villers, Bernard Malavaud, Seasonality of Serum Prostate-Specific Antigen Levels: A Population-Based Study, European Urology, 2007, 52, 3, 708

    CrossRef

  25. You have free access to this content25
    David Feldman, Aruna Krishnan, Jacqueline Moreno, Srilatha Swami, Donna M. Peehl, Sandy Srinivas, Vitamin D Inhibition of the Prostaglandin Pathway as Therapy for Prostate Cancer, Nutrition Reviews, 2007, 65,
  26. 26
    Josephia R. Muindi, Yibing Peng, John W. Wilson, Candace S. Johnson, Robert A. Branch, Donald L. Trump, Monocyte fructose 1,6-bisphosphatase and cytidine deaminase enzyme activities: potential pharmacodynamic measures of calcitriol effects in cancer patients, Cancer Chemotherapy and Pharmacology, 2006, 59, 1, 97

    CrossRef

  27. 27
    Michael Kolodziej, Marcus A. Neubauer, Steven R. Rousey, Robert E. Pluenneke, George Perrine, Stephanie Mull, Kristi A. Boehm, Des Ilegbodu, Lina Asmar, Phase II Trial of Docetaxel/Capecitabine in Hormone-Refractory Prostate Cancer, Clinical Genitourinary Cancer, 2006, 5, 2, 155

    CrossRef

  28. 28
    Donald L. Trump, Douglas M. Potter, Josephia Muindi, Adam Brufsky, Candace S. Johnson, Phase II trial of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancer, Cancer, 2006, 106, 10
  29. 29
    R Vieth, R Choo, L Deboer, C Danjoux, GC Morton, L Klotz, Rise in Prostate-Specific Antigen in Men with Untreated Low-Grade Prostate Cancer Is Slower During Spring-Summer, American Journal of Therapeutics, 2006, 13, 5, 394

    CrossRef

  30. 30
    Hilary Glen, Jim Cassidy, Vitamin D (and its analogs) in the treatment and prevention of cancer, Expert Review of Anticancer Therapy, 2006, 6, 3, 305

    CrossRef

  31. 31
    Tomasz M. Beer, Anne Myrthue, Prostate Cancer: Translational and Emerging Therapies, 2006,

    CrossRef

  32. 32
    JOELLEN WELSH, Nutritional Oncology, 2006,

    CrossRef

  33. 33
    Tomasz M. Beer, ASCENT: The androgen-independent prostate cancer study of calcitriol enhancing taxotere, BJU International, 2005, 96, 4
  34. 34
    G. Kesava Reddy, Preeta Tyagi, Arif Hussain, Vinay K. Jain, Oliver Sartor, Highlights from the 41st Annual Meeting of the American Society of Clinical Oncology May 2005 and the 2005 American Society of Clinical Oncology Prostate Cancer Symposium February 2005 Orlando, Florida, Clinical Prostate Cancer, 2005, 4, 1, 7

    CrossRef

  35. 35
    John M. Strother, Tomasz M. Beer, Robert Dreicer, Novel cytotoxic and biological agents for prostate cancer: Where will the money be in 2005?, European Journal of Cancer, 2005, 41, 6, 954

    CrossRef

  36. 36
    Josephia R. Muindi, Douglas M. Potter, Yibing Peng, Candace S. Johnson, Donald L. Trump, Pharmacokinetics of liquid calcitriol formulation in advanced solid tumor patients: comparison with caplet formulation, Cancer Chemotherapy and Pharmacology, 2005, 56, 5, 492

    CrossRef

  37. 37
    Tony Choon Seng Woo, Richard Choo, Mary Jamieson, Sarat Chander, Reinhold Vieth, Pilot Study: Potential Role of Vitamin D (Cholecalciferol) in Patients With PSA Relapse After Definitive Therapy, Nutrition and Cancer, 2005, 51, 1, 32

    CrossRef

  38. 38
    Andrew Tom Bates, Tom Pickles, Chuck Paltiel, PSA doubling time kinetics during prostate cancer biochemical relapse after external beam radiation therapy, International Journal of Radiation Oncology*Biology*Physics, 2005, 62, 1, 148

    CrossRef

  39. 39
    Tomasz M. Beer, Anne Myrthue, Kristine M. Eilers, Rationale for the development and current status of calcitriol in androgen-independent prostate cancer, World Journal of Urology, 2005, 23, 1, 28

    CrossRef

  40. You have free access to this content40
    JONATHAN L WRIGHT, DANIEL W LIN, PUNEET DEWAN, R BRUCE MONTGOMERY, Tumor lysis syndrome in a patient with metastatic, androgen independent prostate cancer, International Journal of Urology, 2005, 12, 11
  41. 41
    DONALD L. TRUMP, JOSEPHIA MUINDI, CANDACE S. JOHNSON, PAMELA A. HERSHBERGER, Vitamin D, 2005,

    CrossRef

  42. 42
    JOHANNES P.T.M. VAN LEEUWEN, HUIBERT A.P. POLS, Vitamin D, 2005,

    CrossRef

  43. 43
    MISHAELA R. RUBIN, SUSAN THYS-JACOBS, FREDRIECH K.W. CHAN, LILIA M.C. KOBERLE, JOHN P. BILEZIKIAN, Vitamin D, 2005,

    CrossRef

  44. 44
    ARUNA V. KRISHNAN, DONNA M. PEEHL, DAVID FELDMAN, Vitamin D, 2005,

    CrossRef

  45. 45
    Lyndon M. Gommersall, Farhat L. Khanim, Donna M. Peehl, Alan H. Doherty, Moray J. Campbell, Epigenetic repression of transcription by the Vitamin D3 receptor in prostate cancer cells, The Journal of Steroid Biochemistry and Molecular Biology, 2004, 89-90, 251

    CrossRef

  46. 46
    Tomasz M. Beer, Mark Garzotto, Nina M. Katovic, High-Dose Calcitriol and Carboplatin in Metastatic Androgen-Independent Prostate Cancer, American Journal of Clinical Oncology, 2004, 27, 5, 535

    CrossRef

  47. 47
    Donna M. Peehl, David Feldman, Interaction of nuclear receptor ligands with the Vitamin D signaling pathway in prostate cancer, The Journal of Steroid Biochemistry and Molecular Biology, 2004, 92, 4, 307

    CrossRef

  48. 48
    Jian Feng Ma, Larisa Nonn, Moray J Campbell, Martin Hewison, David Feldman, Donna M Peehl, Mechanisms of decreased Vitamin D 1α-hydroxylase activity in prostate cancer cells, Molecular and Cellular Endocrinology, 2004, 221, 1-2, 67

    CrossRef

  49. 49
    Matthew R. Smith, Judith Manola, Donald S. Kaufman, Daniel George, William K. Oh, Elisabetta Mueller, Susan Slovin, Bruce Spiegelman, Eric Small, Philip W. Kantoff, Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy, Cancer, 2004, 101, 7
  50. 50
    Nancy Price, Amy D'Orazio, Vinay K. Jain, Oliver Sartor, The Development of Vitamin D–Based Therapies for Prostate Cancer, Clinical Prostate Cancer, 2004, 2, 4, 202

    CrossRef

  51. 51
    Joanna Wietrzyk, Marzena Pełczyńska, Janusz Madej, Stanisław Dzimira, Halina Kuśnierczyk, Andrzej Kutner, Wiesław Szelejewski, Adam Opolski, Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191), Steroids, 2004, 69, 10, 629

    CrossRef

  52. 52
    Tomasz M Beer, Development of weekly high-dose calcitriol based therapy for prostate cancer, Urologic Oncology: Seminars and Original Investigations, 2003, 21, 5, 399

    CrossRef

  53. 53
    Jörg Reichrath, Martin Rech, Markus Seifert, Vitamin D-induced apoptosis and melanoma: does calpain represent the major execution protease rather than caspases?, The Journal of Pathology, 2003, 201, 2